GlobalData forecasts the hepatitis B therapeutics market will more than double to $3.2B by 2034, driven by functional cure ...
The Global Immuno-oncology Clinical Trials Market is expanding steadily due to the rise in cancer incidence, rapid scientific progress in immunotherapy, and growing investments in precision oncology ...
Markets End the Week Lower as AI Stocks Slide and Gold Hits a Record U.S. stocks ended the week lower as investors pulled ...